{"disease":{"id":"hypertension-hyperlipidemia","name":"hypertension hyperlipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03536598","title":"Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT03566316","title":"Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"IlDong Pharmaceutical Co Ltd","has_results":false},{"nct_id":"NCT03847506","title":"Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT03103256","title":"Clinical Trial to Evaluate the Efficacy and Safety of YHP1701","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT02995720","title":"A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03461081","title":"Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}